Copyright 2018 Zacks Investment Research | 10 S Riverside Plaza Suite #1600 | Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +25.26% per year. These returns cover a period from January 1, 1988 through December 3, 2018. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations.
Visit performance for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
Investment Ideas: Archive
Four Biotech Stocks That Popped More Than 50% in 2018
by Zacks Equity Research
The biotech sector has failed to impress the investors in 2018 which has underperformed the broader S&P 500 market. However, we provide four biotech companies which performed well in this scenario.
VNDA VCEL NCNA GHDX
biotechs
Johnson and Johnson Shares Rocked by Asbestos Allegations
by David Borun
Shares fall 10% on reports company executives knew about harmful contamination
JNJ
medical
Is the Worst Over for Apple?
by David Borun
Though recent events and heavy selling have hurt lately, the best may well be yet to come.
FB AMZN AAPL
computers
Can the Fed Stop the Bleeding?
by David Borun
Chairman Jerome Powell is walking a tight line between reigning in inflation and promoting growth
CME
finance
Amid the Turmoil, Tesla Stands Out - and Short Sellers are Feeling the Heat
by David Borun
With Tesla well outperforming the markets,the short sellers' arguments are falling apart
TSLA GM FCAU F
auto-tires-trucks
This Week's Best Earnings Chart May Surprise You
by Tracey Ryniec
Lululemon and Ulta have been hot, but this other, little-known retailer, has the most amazing chart of them all.
ULTA OLLI LULU
retail
Could iPhones Really be Made in the USA?
by David Borun
With the Trump administration threatening tariffs, does Apple actually have a choice?
AAPL
computers
A Look at the Economic Impact of the California Wildfires
by David Borun
Insurance, Utilities and Homebuilders are among the industries likley to be impacted by the disaster
PHM PCG LEN KBH EIX ALL AIG
insurance
US Automakers are Showing Strong Results
by David Borun
GM is the latest US automaker to rally on a strong quarterly report
TSLA GM F
auto-tires-trucks
GE's recovery is Derailed by a Poor Quarter and a Slashed Dividend
by David Borun
Top and Bottom line misses, a dividend cut and a DOJ investigation point to continued pain
GE
industrial-products
The Bright Side - How a Painful Correction Can Be Healthy
by David Borun
The reaction to Amazon's latest results is an example of intelligent behavior that will benefit the markets in the long run
AMZN
internet
Why Tesla May Deliver a Big Earnings Beat
by David Borun
The electric automaker is about to report the results of one of its most important quarters ever.
TSLA
auto-tires-trucks
The Markets Breathe a Sigh of Relief as the Big Banks Beat Estimates
by David Borun
Goldman Sachs and Morgan Stanley are the latest big banks to beat expectations
MS JPM GS C BK BAC
finance
First Round of Bank Earnings is Positive, What???s on Deck?
by David Borun
Citigroup, JP Morgan and Wells Fargo get bank earnings season off to a strong start
WFC USB MS JPM GS C BK BAC
Why the Yield Curve Signals Health, not Danger
by David Borun
Rising rates are not necessarily bad for the economy...or stocks
WFC JPM C
finance
Looking for a Bright Spot this Week? Look at GE
by David Borun
Investors are cheering the recent management change, even in a tough market
GE
industrial-products
Could a Buyout Save Papa John's?
by David Borun
Rumors of interest from Hedge Fund Giant Trian is lifting shares of Papa John's
PZZA
consumer-discretionary
Before the Jobs Report, CareerBuilder Data Offers a Glimpse at Employment Growth
by David Borun
A new study finds anemic jobs growth in middle-wage positions
TGT COST APO AMZN
Amazon Raises its Minimum Wage to $15/hour
by David Borun
Will other large retailers be forced to follow suit in a tight labor market?
WMT TGT COST AMZN
Myths and Misgivings about Low Priced Stocks
by Brian Bolan
Don't let superstition keep you from making big profits. Brian Bolan will separate the truth from fiction in low-priced stock investing.
Tesla Production and Delivery Numbers Match Expectations
by David Borun
After meeting production forecasts, shares are slightly lower on China concerns
TSLA
US, Canada Replace NAFTA With New Trade Deal: 5 Auto Picks
by Swarup Gupta
The auto rules of origin, which the deal lays out, means those gains will ultimately accrue to U.S. automakers.
OSK MTOR CVGI CMI ALSN
Musk Settles and Tesla Rallies, What's Next?
by David Borun
With the SEC lawsuit apparently behind him, investors focus on quarterly production numbers.
TSLA
A Big Leadership Change Gives GE Investors Reason for Optimism
by David Borun
Flannery is out as Lawrence Culp takes over the effort to turn things around at the industrial giant
GE
Would Tesla be Better Off with a New CEO?
by David Borun
As Elon Musk faces an SEC lawsuit, the company must make contingency leadership plans
TSLA JPM CRM